Abiopharma

Warrants Listing - Structured Warrants: Proposed Issue of Call Warrants

Director Ding Kun 🟡 adjusted position in 7.0K shares (1 derivative) of JD.com, Inc. (JD) Transaction Date: Aug 14, 2026 | Filing ID: 097445

(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Files Form 8-K

Mandatory Cash Dividend/ Distribution:

OmniAb - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

Register of shareholders, changes and capital status - vesting of RSU units into shares - periodic report amendment

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

Warrants Listing - Structured Warrants: Proposed Issue of Call Warrants

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2026

TTM Technologies, Inc. Continues Global Growth Strategy with Planned Acquisition of Epiq Solutions, Enhancing Technologically Differentiated Market Offerings

Centene Announces Planned Chief Financial Officer Transition

Townsquare Announces Strategic Digital Advertising Partnership with Midlands Media Group

Global Warming Solutions Provides Corporate Update and Outlines Path Forward

Dingdong to Report Second Quarter 2026 Financial Results on August 20, 2026